Pathophysiology and diagnosis of hibernating myocardium in patients with post-ischemic heart failure: The contribution of PET

Annals of Nuclear Medicine

Volumn 17, Issue 5, 2003, Pages 341-350

  Camici, Paolo G ^a,b   Rimoldi, Ornella E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Congestive heart failure; Coronary artery disease; Myocardial blood flow; Myocardial metabolism; Positron emission tomography

Indexed keywords

ADULT; AGED; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL HIBERNATION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUNNED HEART MUSCLE;

EID: 0041317721     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03006599     Document Type: Review

References (87)

1. Bonow RO. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 1995; 75 (3): 17A-25A.
2. Eitzman D, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20 (3): 559-565.
3. Pagano D, et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998; 79 (3): 281-288.
4. Gerber BL, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996; 94 (4): 651-659.
5. Samady H, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999; 100 (12): 1298-1304.
6. vom Dahl J, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994; 90 (5): 2356-2366.
7. Pagano D, et al. Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival. Heart 1999; 82 (6): 684-688.
8. Pagley PR, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96 (3): 793-800.
9. Dreyfus GD, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994; 57 (6): 1402-1407; discussion 1407-1408.
10. Di Carli MF, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92 (12): 3436-3444.
11. Bonow RO. The hibernating myocardium: identification of viable myocardium in patients with coronary artery disease and chronic left ventricular dysfunction. Basic Res Cardiol 1995; 90 (1): 49-51.
12. Bax JJ, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001; 104 (12 Suppl 1): 1314-1318.
13. Fath-Ordoubadi F, et al. Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction. Am J Cardiol 1998; 82 (1): 26-31.
14. Tillisch J, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314 (14): 884-888.
15. Brunken R, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73 (5): 951-963.
16. Bax JJ, et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30 (6): 1451-1460.
17. Armstrong WF, et al. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; 11 (1): 97-104.
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237 (3): E214-E223.
19. Paternostro G, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996; 98 (9): 2094-2099.
20. Paternostro G, et al. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 1999; 42 (1): 246-253.
21. Marinho NV, et al. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996; 93 (4): 737-744.
22. Iozzo P, et al. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002; 51 (10): 3020-3024.
23. Fath-Ordoubadi F, et al. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart 1999; 82 (2): 210-216.
24. Meluzin J, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998; 32 (4): 912-920.
25. 201T1 tomography versus dobutamine echocardiography. Circulation 1996; 94 (11): 2712-2719.
26. Brosius FC 3rd, et al. Increased sarcolemmal glucose transporter abundance in myocardial ischemia. Am J Cardiol 1997; 80 (3A): 77A-84A.
27. Depre C, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995; 268 (3 Pt 2): H1265-H1275.
28. Maes A, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994; 90 (2): 735-745.
29. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87: 2070.
30. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72 (6 Pt 2): V123-V135.
31. Heusch G. Hibernating myocardium. Physiol Rev 1998; 78 (4): 1055-1085.
32. Camici PG, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997; 96 (9): 3205-3214.
33. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 1979; 3 (3): 299-308.
34. Camici PG, Rosen SD, Spinks TJ. Positron Emission Tomography, in Nuclear Medicine in Clinical Diagnosis and Treatment, Murray IPC, EII PJ (eds), London; Churchill-Livingstone, 1998: 1353-1368.
35. Hoffman EJ, Phelps ME. Positron emission tomography: principles and quantitation, in Positron emission tomography and autoradiography: principles and applications for the brain and for the heart, Phelps ME, Mazziotta J, Schelbert H (eds), New York; Raven Press, 1986: 113-148.
36. Bergmann SR, et al. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989; 14 (3): 639-652.
37. Araujo LI, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991; 83 (3): 875-885.
38. 15O. Circulation 1984; 70 (4): 724-733.
39. 15O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988; 78 (1): 104-115.
40. Schelbert HR, et al. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 1979; 43 (2): 209-218.
41. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989; 80 (5): 1328-1337.
42. Bellina CR, et al. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. J Nucl Med 1990; 31 (8): 1335-1343.
43. Hutchins GD, et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15 (5): 1032-1042.
44. 15O-labeled water and PET. J Nucl Med 1999; 40 (11): 1848-1856.
45. 15O]water techniques. Circulation 1996; 93 (11): 2000-2006.
46. 15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993; 87 (2): 512-525.
47. Camici PG, et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur Heart J 1996; 17 (1): 25-34.
48. Camici PG, Rosen SD. Does positron emission tomography contribute to the management of clinical cardiac problems? Eur Heart J 1996; 17 (2): 174-181.
49. Austin RE Jr, et al. Profound spatial heterogeneity of coronary reserve. Discordance between patterns of resting and maximal myocardial blood flow. Circ Res 1990; 67 (2): 319-331.
50. Bassingthwaighte JB, King RB, Roger SA. Fractal nature of regional myocardial blood flow heterogeneity. Circ Res 1989; 65 (3): 578-590.
51. Czernin J, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88 (1): 62-69.
52. Nagamachi S, Czernin J, Kim AS. Reproducibility of measurement of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996; 37: 1626-1631.
53. Johnson JA, Cavert HM, Lifson N. Kinetics concerned with distribution of isotopic water in isolated dog heart and skeletal muscle. Am J Physiol 1952; 171: 687-693.
54. Yipintsoi T, Bassingthwaighte JB. Circulatory transport of iodoantipyrine and water in the isolated dog heart. Circ Res 1970; 27 (3): 461-477.
55. 3 by myocardium on metabolic factors and its implications for quantitative assessment of perfusion. Circulation 1980; 61 (1): 34-43.
56. Camici PG, Spinks TJ. Advance imaging-PET, in Challenges in acute coronary syndromes, de Bono DSB (ed), Oxford; Blackwell Science, 1998: 148-172.
57. de Silva R, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992; 86 (6): 1738-1742.
58. 2 and positron emission tomography: comparison of tracer models. Clin Phys Physiol Meas 1992; 13 (1): 1-20.
59. Iida H, et al. Myocardial tissue fraction-correction for partial volume effects and measure of tissue viability. J Nucl Med 1991; 32 (11): 2169-2175.
60. Gerber BL, et al. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. J Nucl Med 1998; 39 (10): 1655-1662.
61. Iida H, et al. Myocardial tissue fraction correction for partial volume effects and measure of tissue viability. J Nucl Med 1991;32:2169-2175.
62. Canty JM Jr, Fallavollita JA. Resting myocardial flow in hibernating myocardium: validating animal models of human pathophysiology. Am J Physiol 1999; 277 (1 Pt 2): H417-H422.
63. Vanoverschelde JL, et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000; 85 (12): 1432-1439.
64. Vanoverschelde JL, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87 (5): 1513-1523.
65. Uren NG, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994; 330 (25): 1782-1788.
66. Di Carli M, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995; 91 (7): 1944-1951.
67. Rosen SD, et al. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996; 124 (11): 939-949.
68. Deanfield JE, et al. Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 1983; 2 (8353): 753-758.
69. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66 (6): 1146-1149.
70. Heyndrickx GR, et al. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975: 56 (4): 978-985.
71. Ambrosio G, et al. Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease. Circulation 1996; 94 (10): 2455-2464.
72. Barnes E, et al. Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia. Heart 2000; 83 (3): 283-289.
73. Barnes E, et al. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol 2002; 39 (3): 420-427.
74. Barnes E, et al. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol 2002; 282 (5): H1603-H1608.
75. Ross J Jr. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation 1991; 83 (3): 1076-1083.
76. Pagano D, et al. Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. Heart 2001; 85 (2): 208-212.
77. Pagano D, et al. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000; 83 (4): 456-461.
78. Czernin J, et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation 1993; 88 (3): 884-895.
79. Sambuceti G, et al. Regional myocardial blood flow in stable angina pectoris associated with isolated significant narrowing of either the left anterior descending or left circumflex coronary artery. Am J Cardiol 1993; 72 (14): 990-994.
80. Sun KT, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94 (12): 3146-3154.
81. Brunelli C, et al. Improvement of hibernation in the clinical setting. J Mol Cell Cardiol 1996; 28 (12): 2415-2418.
82. Marzullo P, et al. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities. J Am Coll Cardiol 1995; 26 (2): 342-350.
83. Conversano A, et al. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J 1996; 131 (3): 440-450.
84. Mäki M, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996; 93 (9): 1658-1666.
85. Mäki MT, et al. Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium. Am J Physiol 1997; 273 (5 Pt 2): H2473-H2480.
86. Grandin C, et al. Delineation of myocardial viability with PET. J Nucl Med 1995; 36 (9): 1543-1552.
87. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol 1999; 33 (3): 678-686.